NARP mitochondriopathy: An unusual cause of progressive myoclonic epilepsy

Neurology

Volumn 68, Issue 17, 2007, Pages 1429-1430

  Jung, J ^a,e   Mauguiere F ^a,e   Clerc Renaud, P ^b   Ollagnon, E ^c   De Camaret, B Mousson ^b   Ryvlin, P ^a,d,e  

^a HÔPITAL NEUROLOGIQUE   (France)

^b HÔPITAL DEBROUSSE   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MYOCLONUS EPILEPSY; NARP SYNDROME; NEUROLOGIC EXAMINATION; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; TREATMENT OUTCOME;

DNA, MITOCHONDRIAL; ELECTROENCEPHALOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; GAIT ATAXIA; HUMANS; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MUTATION, MISSENSE; MYOCLONIC EPILEPSIES, PROGRESSIVE; ORGAN SPECIFICITY; PHENOTYPE; PHOTIC STIMULATION; POINT MUTATION;

EID: 34247473345     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000264019.53959.10     Document Type: Article

References (7)

1. Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005;4:239-248.
2. Ferlin T, Landrieu P, Rambaud C, et al. Segregation of the G8993 mutant mitochondrial DNA through generations and embryonic tissues in a family at risk of Leigh syndrome. J Pediatr 1997;131:447-449.
3. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-433.
4. Uziel G, Moroni I, Lamantea E, et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997;63:16-22.
5. Ortiz RG, Newman NJ, Shoffner JM, Kaufman AE, Koontz DA, Wallace DC. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol 1993;111:1525-1530.
6. Santorelli FM, Tanji K, Shanske S, DiMauro S. Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology 1997;49:270-273.
7. Parfait B, de Lonlay P, von Kleist-Retzow JC, et al. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia. Eur J Pediatr 1999;158:55-58.